John T. Treace Insider Profile
11 Followers
John T. Treace, CEO, Director, Ten Percent Owner at Treace Medical Concepts, holds 12.73M shares in Treace Medical Concepts (Ticker: TMCI). Most recently, John T. Treace Bought 55,944 shares of Treace Medical Concepts on Aug 24, 2026 for an estimated value of $246.28K.
John T. Treace Treace Medical Concepts (TMCI)CEO, Director, Ten Percent Owner
Treace Medical Concepts (TMCI)
CEO, Director, Ten Percent Owner
Ranked #3,485 out of 108,921 Corporate Insiders
Profitable Transactions
18 out of 19 Profitable Transactions
Average Return
+24.10%
Average return per transaction
Time Frame
Compare to
Insider Roles
CEO, Director, Ten Percent Owner
Roles that John T. Treace holds in companies
Most Profitable Insider Trade
The most profitable trade made by John T. Treace
John T. Treace's Trading History
List of latest transactions for each holding click on a transaction to see John T. Treace's performance on stock
You May Also Like
John T. Treace insider profile FAQ
What is the percentage of profitable transactions made by John T. Treace?
The percentage of profitable transactions made by John T. Treace is 95%.
What is the average return per transaction made by John T. Treace?
The average return per transaction made by John T. Treace is 24.10%.
What stocks does John T. Treace hold?
John T. Treace holds: TMCI stocks.
What was John T. Treace’s latest transaction?
John T. Treace latest transaction was an Informative Buy of $246.28K.
What was John T. Treace's most profitable transaction?
John T. Treace’s most profitable transaction was an Informative Buy of TMCI stock on May 14, 2026. The return on the trade was 73.60%.
What is John T. Treace's role in Treace Medical Concepts?
John T. Treace's role in Treace Medical Concepts is CEO, Director, Ten Percent Owner.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.